SXTP - 60degreespharma.com Annual Revenue Growth (Last Twelve Months)

Graphic logo of 60degreespharma.com (SXTP)

The year-over-year sales volume growth trajectory for the trailing year on GURU.Markets helps assess the efficiency of the fabless model at 60 Degrees Pharmaceuticals (SXTP), where testing and pill production are outsourced to third-party contractors. The business generates revenue from supplying antimalarial drugs to the military and residents of tropical regions. Collaboration with proven vendors ensures scaling without production disruptions, and the current metric is recorded at 24.60.

60degreespharma.com (SXTP) Sales Growth YoY (Last Twelve Months): for the period 11/23/2025 - 11/18/2026

Analytical breakdowns and data insights for company 60 Degrees Pharmaceuticals, Inc. (SXTP)

- current price and projected stock value:
Fundamental company valuation:60degreespharma.com
Signature product of 60degreespharma.com

For 60 Degrees Pharmaceuticals (SXTP), which develops anti-malarial drugs through US government contracts, the year-over-year revenue growth trend on a rolling basis reflects the efficiency of commercializing scientific research. This indicator calculates TTM sales dynamics, allowing investors to differentiate business expansion from capital stagnation by assessing current income growth rates relative to the same period last year.